Core Scientific, Inc.
CORZ
$16.42
-$0.55-3.24%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 79.93% | 28.43% | -44.37% | -2,915.91% | -483.35% |
| Total Depreciation and Amortization | -33.25% | -24.35% | -11.87% | 6.46% | 24.55% |
| Total Amortization of Deferred Charges | 59.58% | 94.93% | 219.45% | 241.93% | 399.47% |
| Total Other Non-Cash Items | -103.17% | -57.35% | 14.52% | 2,120.35% | 2,819.59% |
| Change in Net Operating Assets | 1,997.94% | 311.03% | 276.61% | -79.74% | -116.55% |
| Cash from Operations | 548.66% | 173.63% | -74.43% | -129.51% | -34.12% |
| Capital Expenditure | -667.68% | -520.38% | -445.64% | -225.67% | -487.59% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -6,484.85% | -8,160.87% | -2,007.38% | -796.55% | 72.27% |
| Cash from Investing | -678.16% | -674.94% | -665.81% | -373.40% | -3,077.30% |
| Total Debt Issued | -- | 36.31% | -- | -- | -- |
| Total Debt Repaid | 87.84% | 83.90% | -373.19% | -389.56% | -596.22% |
| Issuance of Common Stock | -88.46% | -91.71% | -90.70% | -90.64% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -109.35% | -123.15% | -123.15% | -- |
| Cash from Financing | -107.70% | 174.19% | 13,454.72% | 6,989.02% | 1,935.58% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -168.50% | 5.15% | 2,280.14% | 1,199.24% | 4,292.19% |